Post Archive by Day

While no approved vaccines target Parkenson's disease (PD), several clinical pathways are being investigated with innovative technologies in 2024. 
Different monoclonal antibodies have been investigated as passive immunization, and novel active immunization modalities targeting PD are being studied.
Recently, the findings of a non-peer-reviewed study reveal a significant reduction in PD occurrence following anti-tetanus vaccination, with a time-dependent association between the elapsed time since vaccination and the rate and progression of PD.

Bharat Biotech International Limited (BBIL) recently stated X that the company unintentionally omitted the Indian Council of Medical Research (ICMR) as a co-owner of the inactivated COVAXIN® vaccine patent.
On June 22, 2024, the Hyderabad-based vaccine producer Tweeted that it was taking legal action to correct this issue.
According to media reporting, ICMR was to receive a 5% royalty on net sales and product branding rights, which include 'co-inventor' status.